-
Entity
-
Individual
-
Location
-
C/O Brooklyn Immunotherapeutics, Inc., 140 58 Th Street, Building A, Suite 2100, Brooklyn, NY
-
Summary
-
The estimated net worth of Kevin DAmour is at least $159K dollars as of June 29, 2022. Kevin DAmour is the Chief Scientific Officer of Brooklyn ImmunoTherapeutics, Inc. and owns shares of Eterna Therapeutics Inc. (ERNA) stock worth about $159K.